Live tape
Top 8, mentions 7d7,638NVDA1,345 mentions▲ +0.09GOOGL1,167 mentions▲ +0.04AVGO1,034 mentions▲ +0.05NKE1,030 mentions+0.01LULU964 mentions▲ +0.03TSLA923 mentions▲ +0.06META634 mentions▲ +0.05QQQ541 mentions▲ +0.08

Equity · Healthcare

PBH

Prestige Consumer Healthcare Inc. · NYSE

$52.18 +1.44% 1D Finazon · prior-day close · Aug 26, 2026
Price · Chart
Our own end-of-day closes 51 sessions
$60 $40 10 Jun 26 Aug

The line runs $49.08 on 10 June through $52.18 on 26 August, on a scale from $40 to $60. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of PBH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 51 sessions over that window: $49.08 on 10 June 2026 through $52.18 on 26 August 2026.

Market cap $2.5B
P/E (TTM) 15.4
52-week range $45 – $70
Avg volume 86.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026

PBH insider trades

SEC Form 4

PBH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 December 2025.

Date Insider Type Shares Value
01 Dec 2025 Zerillo Jeffrey Senior VP Operations Sell 281 $17K
28 Nov 2025 Zerillo Jeffrey Senior VP Operations Sell 719 $43K
25 Nov 2025 BYOM JOHN E Sell 3,000 $178K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
05 Aug 2025 Hopkins Sheila Award 2,094
05 Aug 2025 Clark Celeste A. Award 2,094
05 Aug 2025 BYOM JOHN E Award 2,094
05 Aug 2025 DArecca James Award 2,094
05 Aug 2025 ZIER DAWN M. Award 2,094
05 Aug 2025 Kelly John F. Award 2,094

PBH reported financials

SEC EDGAR XBRL

PBH reported revenue of $1.1B for the fiscal year ended 31 Mar 2026. Net income over the same period was $190.3M.

Figure Reported Period
Revenue $1.1B 31 Mar 2026 fiscal year
Net income $190.3M 31 Mar 2026 fiscal year
Diluted EPS $3.91 31 Mar 2026 fiscal year
Total assets $4.6B 30 Jun 2026 at period end
Total equity $1.9B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

PBH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q1 2027 $0.61 —
31 Mar 2026 FY 2026 $3.91 —
31 Dec 2025 Q3 2026 $0.97 —
30 Sep 2025 Q2 2026 $0.86 —
30 Jun 2025 Q1 2026 $0.95 —
31 Mar 2025 FY 2025 $4.29 —
31 Dec 2024 Q3 2025 $1.22 —
30 Sep 2024 Q2 2025 $1.09 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

PBH institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a PBH position for the quarter ended 30 Jun 2026 — a combined $69.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Added +207.5% shares 564,157 $26.7M
D. E. Shaw & Co. Held (±25%) −17.7% shares 313,778 $14.8M
Fisher Asset Management Held (±25%) −1.5% shares 247,474 $11.7M
Man Group Held (±25%) −12.8% shares 119,056 $5.6M
Maverick Capital New position 50,975 $2.4M
Bridgewater Associates New position 46,407 $2.2M
Millennium Management Trimmed −82.1% shares 46,340 $2.2M
AQR Capital Management Held (±25%) +0.7% shares 37,005 $1.7M
Marshall Wace Trimmed −43.9% shares 31,011 $1.5M
Two Sigma Investments Trimmed −36.8% shares 4,300 $203K

Source: SEC EDGAR 13F filings

PBH fails-to-deliver

SEC CNS data

On 10 Aug 2026, 178 shares of PBH failed to deliver (about $10K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
10 Aug 2026 178 $10K <0.001%
07 Aug 2026 3,174 $173K 0.007%
05 Aug 2026 721 $37K 0.002%
04 Aug 2026 112 $6K <0.001%
03 Aug 2026 71 $4K <0.001%
30 Jul 2026 266 $14K 0.001%
28 Jul 2026 73 $4K <0.001%
27 Jul 2026 40 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data